Decrease in Pediatric Invasive Pneumococcal Disease During the COVID-19 Pandemic

Area of Science:

• Epidemiology
• Infectious Diseases
• Public Health

Background:

• Non-pharmaceutical interventions (NPIs) were implemented globally in 2020 to curb severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission.
• These measures, including masking, social distancing, and enhanced hygiene, significantly altered respiratory virus circulation patterns.
• The impact of these NPIs on other bacterial and viral infections, particularly in pediatric populations, remains an area of active investigation.

Purpose of the Study:

• To investigate the effect of SARS-CoV-2 containment measures on the incidence of invasive pneumococcal disease (IPD) in children.
• To determine if the reduction in other viral infections influenced IPD rates.
• To explore potential mechanisms linking reduced viral transmission to changes in IPD incidence.

Main Methods:

• Retrospective analysis of IPD case data from 7 children's hospitals in the United States.
• Comparison of cumulative incidence of IPD in 2020 with a baseline period of 2017-2019.
• Statistical analysis to assess the significance of observed changes in incidence.

Main Results:

• A 46% decrease in the cumulative incidence of invasive pneumococcal disease was observed in 2020 compared to the 2017-2019 average.
• The reduction in IPD occurred concurrently with widespread implementation of measures to limit SARS-CoV-2 transmission.
• This finding suggests a potential link between reduced transmission of respiratory viruses and decreased rates of IPD.

Conclusions:

• Non-pharmaceutical interventions aimed at controlling SARS-CoV-2 transmission were associated with a significant reduction in invasive pneumococcal disease incidence among children.
• Limited droplet transmission of Streptococcus pneumoniae and the decreased circulation of preceding viral pathogens are plausible explanations for the observed decline in IPD.
• Further research is warranted to elucidate the complex interplay between viral and bacterial respiratory pathogen dynamics under varying public health intervention scenarios.